companydata.dkcompanydata.dk

Pharmaforce ApS: Financial statements 2025

CVR: 26394198

Source: annual report 2025, Danish Business Authority

01/01/202531/12/2025

Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. That is a decrease of 3.7% compared with the year before. Equity in the 2025 report amounted to DKK 4,328,882. The solvency ratio was 65.9%. The company had 4 employees in the financial year.

Gross Profit
DKK 5,238,511
Profit/Loss
DKK 914,232
Equity
DKK 4,328,882
Total Assets
DKK 6,573,345
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-5.2 mio.914 t.4.3 mio.4
2024-5.4 mio.1.5 mio.3.9 mio.4
2023-3.7 mio.262 t.2.9 mio.5
2022-3.6 mio.283 t.2.9 mio.5
2021-4.2 mio.367 t.2.9 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Pharmaforce ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Pharmaforce ApS: The 2024 annual report is outMay 8, 2025

Pharmaforce ApS has published its annual report for 2024. Gross profit came to DKK 5,437,134, and the net result was DKK 1,494,355.

About Pharmaforce ApS

Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity in the 2025 report amounted to DKK 4,328,882.

Source: annual report 2025, Danish Business Authority